FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical modelsTimothy Weeden, Stefano Zanotti, Sean Spring et al.|Communications Medicine|2025Cited by 25
P.27Targeted delivery of oligonucleotide therapeutics to muscle reduces toxic DMPK RNAMohammed Qatanani, Raju Subramanian, Timothy Weeden et al.|Neuromuscular Disorders|2019Cited by 0